Global Lyme Borreliosis Treatment Market, By Type of Bacteria (Borrelia afzelii, Borrelia mayonii, Borrelia garinii, Borrelia burgdorferi, Others), Disease Type (Early Lyme Disease, Lyme Arthritis, Neurologic Lyme disease, Borrelial Lymphocytosis, Post-treatment Lyme Disease Syndrome (PTLDS), Lyme Carditis), Treatment (Antibiotics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Tick Removal, Others), Diagnosis (Enzyme-linked immunosorbent assay (ELISA) test, Western blot test, Others), Dosage (Tablet, Injection, Ointment, Others), Route of Administration (Oral, Injectable, Topical, Others), Application (Human, Animals), Symptoms (Muscle aches, Joint pain, Swelling, Fever, Swollen lymph nodes, Headache, Sleep disturbances, Fatigue, Difficulty concentrating, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.